Regulation on the determination of the non-small amount of doping substances (dopants-quantities-Regulation-DmMV)

Unofficial table of contents

DmMV

Date of completion: 24.06.2013

Full quote:

" Doping Medium-Quantity-Ordination of 24 June 2013 (BGBl. I p. 1687) "

Footnote

(+ + + Text evidence from: 29.6.2013 + + +) 

  

The V was decided as Article 2 of the V v. 24.6.2013 I 1687 by the Federal Ministry of Health in agreement with the Federal Ministry of the Interior after hearing experts with the approval of the Bundesrat. She's gem. Art. 3 sentence 1 of this V entered into force on 29.6.2013. Unofficial table of contents

----

The not small quantity of the substances within the meaning of the first sentence of § 6a (2a) of the Medicines Act is the quantity determined in the plant. The non-small amount is indicated for the free compound of the substance concerned. Unofficial table of contents

Annex

(Fundstelle: BGBl. I 2013, 1688-1692)

I)

Anabolic substances

1.

Anabol-androgenic steroids

a)

Exogenous anabolic androgenic steroids not small quantity

1-androstendiol	3 000 mg
1-Androstendion	3 000 mg
Bolanediol	3 000 mg
Bolasteron
-Depot preparations	100 mg
-other preparations	150 mg
Boldenon	1 000 mg
Boldion	3 000 mg
Calusterone
-Depot preparations	100 mg
-other preparations	150 mg
Clostebol
-Depot preparations	80 mg
-other preparations	900 mg
Danazol	3 000 mg
Dehydrochlormethyltestosterone
-Depot preparations	100 mg
-other preparations	150 mg
Desoxymethyltestosterone
-Depot preparations	100 mg
-other preparations	150 mg
Drostanolon	1 015 mg
Ethylestrenol	450 mg
Fluoxymesterone
-Depot preparations	100 mg
-other preparations	150 mg
Formebolone
-Depot preparations	100 mg
-other preparations	150 mg
Furazabol
-Depot preparations	100 mg
-other preparations	150 mg
Gestrinon	45 mg
4-hydroxytestosterone	1 500 mg
Mestanolon
-Depot preparations	100 mg
-other preparations	150 mg
Mesterolon	1 500 mg
Metandienon
-Depot preparations	100 mg
-other preparations	150 mg
Metenolon
-Depot preparations	150 mg
-other preparations	1 500 mg
Methandriol
-Depot preparations	100 mg
-other preparations	150 mg
Methasterone
-Depot preparations	100 mg
-other preparations	150 mg
Methyldienolone	45 mg
Methyl-1-testosterone
-Depot preparations	100 mg
-other preparations	150 mg
Methylnortestosterone
-Depot preparations	100 mg
-other preparations	150 mg
Methyltestosterone
-Depot preparations	100 mg
-other preparations	150 mg
Metribolon, synonym methyltrienolone	45 mg
Miboleron
-Depot preparations	100 mg
-other preparations	150 mg
Nandrolon	45 mg
19 -Norandrostendion	3 000 mg
Norboleton	450 mg
Norclostebol	1 500 mg
Norethandrolon	450 mg
Oxabolon	75 mg
Oxandrolon
-Depot preparations	100 mg
-other preparations	150 mg
Oxymesterone
-Depot preparations	100 mg
-other preparations	150 mg
Oxymetholone
-Depot preparations	100 mg
-other preparations	150 mg
Prostanozole	1 500 mg
Quinbolon	1 500 mg
Stanozolol
-Depot preparations	100 mg
-other preparations	150 mg
Stenbolon	1 500 mg
1-Testosterone	1 500 mg
Tetrahydrogestrinon	45 mg
Trenbolone	150 mg
Other substances related to anabol-androgenic steroids
-with 17alpha-methyl-structure
-Depot preparations	100 mg
-other preparations	150 mg
-with other structures	3 000 mg

b)

Endogenous anabol-androgenic steroids not small quantity

Androstendiol	3 000 mg
Androstendion	3 000 mg
Androstanolon, synonym dihydrotestosterone	1 500 mg
Prasterone, synonymous with dehydroepiandrosterone (DHEA)
-Depot preparations	144 mg
-other preparations	3 000 mg
Testosterone
-Depot preparations	632 mg
-transdermal preparations	1 500 mg
-other preparations	3 000 mg

2.

Other anabolic substances not small quantity

Clenbuterol	2.1 mg
Selective Androgen Receptor Modulators (SARMs)	90 mg
Tibolon	75 mg
Zeranol	4.5 mg
Zilpaterol	4.5 mg

II)

Peptide hormones, growth factors and related substances

1.

Erythropoiesis stimulatory substances not small quantity

Erythropoietin human (EPO)	24 000 IU
Epoetin alfa, beta, delta, omega, theta, zeta and analogue recombinant human erythropoietin
Darbepoetin alfa (dEPO)	120 µ g
Methoxy-polyethylene glycol-epoetin beta, synonymous with PEG-epoetin beta, Continuous Erythropoiesis Receptor Activator (CERA)	90 µ g
Peginesatid, synonyms Hematid	5 mg

2.

Chorionic gonadotrophin (CG) and Luteinizing Hormon (LH) not small quantity

Chorionic gonadotrophin (HCG)	7 500 IU
Choriogonadotropin alfa	250 µ g
Lutropin alfa	2 250 IU

3.

Corticotropins not small quantity

Corticotropin	1 200 IU
Tetracosactide
-Depot preparations	12 mg
-other preparations	0.25 mg

4.

Growth hormone, release factors, release peptides and growth factors not small quantity

Somatropin, synonymous growth hormone human, Growth Hormone (GH)	16 mg
Somatrem, synonymous with somatotropin (methionyl), human	16 mg
Growth Hormone Release Factors, synonymous with Growth Hormones Releasing Hormones (GHRH)	1.5 mg
Sermorelin
Somatorelin
and peptides having the same effect, synonymous growth hormones
Releasing Peptide (GHRP)
Mecasermin, synonymous with insulin-like growth factor 1, Insulin-like Growth Factor -1 (IGF-1)	60 mg
IGF-1 analogues	3 mg

III)

Hormones and Metabolic Modulators

1.

Aromatasehemmer not small quantity

Aminoglutethimide	30 000 mg
Anastrozole	30 mg
Androsta-1,4,6-trien-3, 17-dione, synonym Androstatriendion	3 000 mg
4-androsten-3,6, 17-trione (6-oxo)	6 000 mg
Exemestan	750 mg
Formestan	600 mg
Letrozole	75 mg
Testolactone	6 000 mg

2.

Selective Estrogen Receptor Modulators (SERMs) not small quantity

Raloxifen	1 680 mg
Tamoxifen	600 mg
Toremifene	1 800 mg

3.

Other antiestrogenic substances not small quantity

Clomifen	509 mg
Cyclofenil	4 200 mg
Fulvestrant	250 mg

4.

Myostatin functions changing substance myostatin inhibitors not small quantity

Stamulumab	450 mg

5.

Metabolism modulators not small quantity

Insulins	400 IU
PPARδ (Peroxisome Proliferator Activated Receptor Delta)-agonists, synonymous PPAR-delta-agonists	75 mg
GW 501516, synonym GW 1516
AMPK (PPARδ-AMP-activated protein kinase)-Axis-agonists	7 000 mg
AICAR